Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
A considerable percentage of deaths in HIV patients are due to cryptococcal infections

Cryptococcal meningitis causes about one in ten HIV-related deaths, according to a study of autopsies performed in Mozambique and Brazil.

Published
22 May 2019
From
Eurekalert Inf Dis
The forgotten generation?

Modern advancements such as U=U have redefined what it means to live with HIV. But, as Ross Duffin reports, for the long-term survivors the lived reality is not so rosy.

Published
21 May 2019
From
Positive Living
Advanced Stage at Cancer Diagnosis, Higher Mortality in US Patients With HIV

Cancer patients with HIV in the U.S. are more likely to be diagnosed at advanced disease stages and experience higher cancer-related mortality than cancer patients without HIV, researchers say.

Published
21 May 2019
From
Reuters
One third of French HIV group uses illicit drugs, often risking antiretroviral interactions

One in 3 people in a 286-person French HIV group took illicit drugs that sometimes posed a risk of severe interactions with antiretrovirals. Many potential interactions involved the boosting agents ritonavir or cobicistat.

Published
17 May 2019
From
NATAP
Rapid rehousing support for homeless people living with HIV improves housing and HIV outcomes

Homeless people with HIV who are provided with rapid rehousing and intensive, tailored case management are placed in stable housing more quickly and are twice as likely to

Published
17 May 2019
By
Michael Carter
US study suggests that ageing people with HIV may have an increased risk of arthritis

HIV infection and antiretroviral therapy are associated with increased risk of cartilage damage in the knee associated with osteoarthritis, according to the results of a small US study

Published
16 May 2019
By
Michael Carter
FDA's Breakthrough Designation Granted for Kaposi Sarcoma Therapy

Celgene’s pomalidomide (Pomalyst) has been granted Breakthrough Therapy designation by the FDA for the treatment of patients with previously-treated HIV-positive Kaposi sarcoma (KS) and patients with HIV-negative KS, according to a press release.

Published
15 May 2019
From
Pharmacy Times
Should Gay Men Be Getting Anal Pap Smears?

It’s time to talk about Pap smears, guys. More specifically, if you’re a man who has sex with other men, or MSM, you should consider talking to your medical provider about getting an anal Pap smear.

Published
13 May 2019
From
Slate
Decline in chemsex over time in three English clinics

In the first study to track chemsex over time, the number of men having chemsex fell by two-thirds between 2015 and 2018, Janey Sewell and

Published
09 May 2019
By
Roger Pebody
Raising the equality flag: Health inequalities among older LGBT people in the UK

New analysis, based on data from 24 different surveys, demonstrates that the odds of lesbian, gay, or bisexual men and women experiencing poor self-rated health are around 1.2 times higher than for heterosexual people, with poor self-rated health being a strong predictor of future mortality.

Published
08 May 2019
From
International Longevity Centre

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.